Literature DB >> 7838

Isoniazid and iproniazid: activation of metabolites to toxic intermediates in man and rat.

S D Nelson, J R Mitchell, J A Timbrell, W R Snodgrass, G B Corcoran.   

Abstract

Acetylhydrazine, a metabolite of isoniazid, a widely used antituberculosis drug, and isopropylhydrazine, a metabolite of iproniazid, an antidepressant removed from clinical use because of high incidence of liver injury, were oxidized by cytochrome P-450 enzymes in human and rat liver microsomes to highly reactive acylating and alkylating agents. Covalent binding of these metabolites to liver macromolecules paralleled hepatic cellular necrosis. The metabolites formed from these and probably other monosubstituted hydrazines are reactive electrophiles.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 7838     DOI: 10.1126/science.7838

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  31 in total

1.  The Isoniazid Metabolites Hydrazine and Pyridoxal Isonicotinoyl Hydrazone Modulate Heme Biosynthesis.

Authors:  Christopher Trent Brewer; Lei Yang; Anne Edwards; Yan Lu; Jonathan Low; Jing Wu; Richard E Lee; Taosheng Chen
Journal:  Toxicol Sci       Date:  2019-03-01       Impact factor: 4.849

Review 2.  Mechanisms of drug toxicity and relevance to pharmaceutical development.

Authors:  F Peter Guengerich
Journal:  Drug Metab Pharmacokinet       Date:  2010-10-22       Impact factor: 3.614

3.  Role of CYP3A in isoniazid metabolism in vivo.

Authors:  Ke Liu; Feng Li; Jie Lu; Zhiwei Gao; Curtis D Klaassen; Xiaochao Ma
Journal:  Drug Metab Pharmacokinet       Date:  2013-10-29       Impact factor: 3.614

4.  A systems biology approach utilizing a mouse diversity panel identifies genetic differences influencing isoniazid-induced microvesicular steatosis.

Authors:  Rachel J Church; Hong Wu; Merrie Mosedale; Susan J Sumner; Wimal Pathmasiri; Catherine L Kurtz; Mathew T Pletcher; John S Eaddy; Karamjeet Pandher; Monica Singer; Ameesha Batheja; Paul B Watkins; Karissa Adkins; Alison H Harrill
Journal:  Toxicol Sci       Date:  2014-05-20       Impact factor: 4.849

5.  Induction of protective autophagy against apoptosis in HepG2 cells by isoniazid independent of the p38 signaling pathway.

Authors:  Tian-Guang Zhang; Yi-Mei Wang; Jun Zhao; Ming-Yu Xia; Shuang-Qing Peng; Takashi Ikejima
Journal:  Toxicol Res (Camb)       Date:  2016-04-04       Impact factor: 3.524

6.  Mechanism-based inactivation of lacrimal-gland peroxidase by phenylhydrazine: a suicidal substrate to probe the active site.

Authors:  A Mazumdar; S Adak; R Chatterjee; R K Banerjee
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

7.  The urinary excretion of phenelzine.

Authors:  B Caddy; A H Stead; E C Johnstone
Journal:  Br J Clin Pharmacol       Date:  1978-08       Impact factor: 4.335

8.  A simple pharmacokinetic method for separating the three acetylation phenotypes: a preliminary report.

Authors:  E J Lee; L K Lee
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

9.  Metal binding by pharmaceuticals. Part 3. Copper (II) and zinc (II) interactions with isoniazid.

Authors:  A Cole; P M May; D R Williams
Journal:  Agents Actions       Date:  1983-02

10.  Detection of anti-isoniazid and anti-cytochrome P450 antibodies in patients with isoniazid-induced liver failure.

Authors:  Imir G Metushi; Corron Sanders; William M Lee; Jack Uetrecht
Journal:  Hepatology       Date:  2014-01-27       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.